Sign In

Stan Lapidus

Board chairman and board member

Stan Lapidus is a prominent figure in the field of diagnostics and medical devices, recognized for his entrepreneurial ventures, inventive spirit, and educational contributions.

With a strong academic foundation in electrical engineering from The Cooper Union for the Advancement of Science and Art, complemented by studies at the prestigious Bronx High School of Science, Stan Lapidus has cultivated a deep understanding of technology and innovation.

Notably, Stan Lapidus is the founding force behind two groundbreaking companies in the realm of cancer early detection: Cytyc Corporation and Exact Sciences Corp. These ventures have left a lasting impact on the diagnostic industry.

His professional journey is marked by key leadership roles and strategic positions on the boards of various organizations. Stan Lapidus has served as Chairman of the Board at Mercy BioAnalytics, Inc., Lucid Diagnostics, Mirvie, and binx health among others.

Additionally, he has lent his expertise as a Vice-Chairman and board member at companies such as Sunbird Bio and Droplet Biosciences, Inc., showcasing his commitment to driving growth and innovation in the biotech sector.

Stan Lapidus has also been actively involved in academia and venture capitalism, having served as an Executive in Residence at the University of Colorado Anschutz Medical Campus, Founder of Pillar VC, and Managing Director at Lapidx Research.

His contributions to the field extend beyond corporate realms, as he has shared his knowledge as an Instructor at MIT, enriching the minds of future innovators.

The breadth of Stan Lapidus's experience is evidenced by his diverse roles, from founder and CEO to executive positions, displaying his versatile skill set and strategic acumen.

Stan Lapidus's journey exemplifies a fusion of entrepreneurship, technological acumen, and educational leadership, making him a respected figure in the world of diagnostics and medical innovation.

Highlights

May 17 · Forbes
Mirvie Raises $60 Million For Blood Test To Predict Pregnancy Complications - Forbes
May 17 · Forbes
Mirvie Raises $60 Million For Blood Test To Predict Pregnancy Complications - Forbes
Mirvie Raises $60 Million For Blood Test To Predict Pregnancy Complications - Forbes
Stan Lapidus
Add to my network

Location

Denver Metropolitan Area